Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Works matching IS 01145916 AND DT 2018 AND VI 41 AND IP 3
Results: 10
1
2
Reported Adverse Events with Painkillers: Data Mining of the US Food and Drug Administration Adverse Events Reporting System.
- Published in:
- 2018
- By:
- Publication type:
- journal article
3
Risk of Psoriasis Following Terbinafine or Itraconazole Treatment for Onychomycosis: A Population-Based Case-Control Comparative Study.
- Published in:
- Drug Safety, 2018, v. 41, n. 3, p. 285, doi. 10.1007/s40264-017-0614-2
- By:
- Publication type:
- Article
4
Authors' Reply to Mona Kargar and Colleagues' Comment on "Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals".
- Published in:
- 2018
- By:
- Publication type:
- Letter
5
Comment on: "Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals".
- Published in:
- 2018
- By:
- Publication type:
- Letter
6
Evaluation of 'Definite' Anaphylaxis Drug Allergy Alert Overrides in Inpatient and Outpatient Settings.
- Published in:
- 2018
- By:
- Publication type:
- journal article
7
Neuropsychiatric Events Associated with Leukotriene-Modifying Agents: A Systematic Review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
8
Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England.
- Published in:
- 2018
- By:
- Publication type:
- journal article
9
Can SGLT2 Inhibitors Cause Acute Renal Failure? Plausible Role for Altered Glomerular Hemodynamics and Medullary Hypoxia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
10
Severe Physical Complications among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article